Oncimmune Holdings plc (ONC) Ordinary 1p

- Add to watchlist
- Create an alert
- This stock can be held in a




30.00p
30.00p
71.00p
£19.87 million
28.40p
26.00p
13.00p
n/a
3.90p (15.92%) Previous:
3.90p
488,014
n/a
7,500
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/08/2022 | 31/05/2021 |
---|---|---|
Revenue (£m) | 3.79 | 3.72 |
Profit before tax (£m) | (11.56) | (6.06) |
Adjusted EPS (p): | (13.17) | (7.73) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Oncimmune sells 'non-core' lung and antibody assets in £13m deal
22 May 2023 11:14
-
Oncimmune enters collaboration with Siemens Healthineers
17 February 2023 15:53
-
Oncimmune agrees two new commercial contracts
8 April 2022 15:44
-
Progress against Strategy
30 November 2023 07:00
-
Holding(s) in Company
10 November 2023 10:14
-
Grant of Options and PDMR Dealing
7 November 2023 16:11
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.